Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT07116096

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Led by Shanxi Provincial People's Hospital · Updated on 2026-01-13

120

Participants Needed

2

Research Sites

51 weeks

Total Duration

On this page

Sponsors

S

Shanxi Provincial People's Hospital

Lead Sponsor

T

The First Affiliated Hospital of Shanxi Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

1. Background Handgrip strength , a core indicator of muscle function, has been confirmed to be significantly associated with the clinical prognosis of patients with liver cirrhosis. However, no studies have explored its correlation with portal venous hemodynamics. 2. Objective The purpose of the study is to examine the effects of Handgrip strength on portal vein and left gastric vein pressure, blood flow velocity and direction in patients with liver cirrhosis, as well as its hemodynamic impact on gastroesophageal varices. 3. Method Study Design: Interventional study. Detection Timing: Hemodynamic indices were measured simultaneously after patients achieved their maximum handgrip strength. Participants were divided into three groups based on the assessment methods. Group 1 (Portal Pressure Measurement Group): Before the placement of TIPS, the pressures of the portal vein and left gastric vein were measured, both before and after the handgrip strength test. Group 2 (Doppler Ultrasound Measurement Group): Measurements of portal flow velocity and direction were taken before and after the handgrip strength test, based on Doppler ultrasound. Group 3 (Endoscopic Ultrasound Measurement Group): Measurements of blood flow volume and direction in esophagogastric varices were conducted before and after the handgrip strength test, based on endoscopic ultrasonography. The inclusion and exclusion criteria were described. 4. Elaboration of the Research Hypothesis 4.1. Core Hypothesis The handgrip strength level in patients with liver cirrhosis is correlated with portal venous system hemodynamic indices. Specifically, enhanced handgrip strength may affect portal hypertension and the hemodynamics of varicose veins by improving systemic muscle function or circulatory status. 4.2. Speculation on potential mechanisms Association between muscle function and circulation: As a representative of systemic muscle function, increased handgrip strength may reflect an increase in cardiac output or changes in splanchnic vascular resistance, thereby influencing portal venous hemodynamics. Effects on varicose veins: Improved handgrip strength may reduce blood flow velocity or diameter of esophagogastric varices by decreasing splanchnic congestion or regulating local vascular tension, thus lowering the risk of variceal rupture and bleeding. Role of compensatory mechanisms: Muscle wasting is common in decompensated cirrhosis. Patients with higher handgrip strength may have better compensatory capacity, and the degree of hemodynamic disorder in their portal venous system may be less severe. Conclusion This study uses a multi-method grouping design to first explore the association between handgrip strength and portal venous hemodynamics in cirrhotic patients. The hypothesis is based on the potential regulatory role of muscle function in the circulatory system, which is expected to provide a new non-invasive indicator for clinical assessment of portal hypertension risk.

CONDITIONS

Official Title

Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 6518 years old
  • Clinically diagnosed with liver cirrhosis
  • Endoscopic observation to determine the presence of esophagogastric varices
  • No signs of variceal bleeding for at least 14 days to be eligible for the portal vein pressure measurement group
  • Participant or guardian is able to understand the study, willing to participate, and can provide written informed consent
Not Eligible

You will not qualify if you...

  • Severe congestive heart failure or severe untreated valvular heart disease
  • Moderate to severe pulmonary hypertension
  • Uncontrolled systemic infection
  • Liver lesions or tumors that prevent TIPS creation
  • Overt hepatic encephalopathy
  • Unrelieved biliary obstruction
  • Child-Pugh score greater than 13
  • MELD score greater than 18
  • INR greater than 5
  • Platelet count less than 20 x 10^9/mm3
  • No gastrointestinal bleeding for the ultrasound and endoscopic ultrasonography groups
  • Hand or wrist surgery in the previous 3 months or inability to hold the dynamometer with the testing hand

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

The First Affiliated Hospital of Henan University of Science and Technology

Luoyang, Henan, China, 471003

Actively Recruiting

2

Shanxi Provincial People's Hospital

Taiyuan, Shanxi, China, 030012

Actively Recruiting

Loading map...

Research Team

M

Mingyuan Zhao, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here